Jesse Erasmus (@jesseerasmus) header
Jesse Erasmus (@jesseerasmus) profile picture

Director of Virology @hdtbio. Developing RNA platform for emerging infectious diseases. 🇿🇦🇰🇷

Seattle, WA
Joined March 2009
Photo by Jesse Erasmus (@jesseerasmus)Photo by Jesse Erasmus (@jesseerasmus)Photo by Jesse Erasmus (@jesseerasmus)Photo by Jesse Erasmus (@jesseerasmus)Photo by Jesse Erasmus (@jesseerasmus)Photo by Jesse Erasmus (@jesseerasmus)Photo by Jesse Erasmus (@jesseerasmus)Photo by Jesse Erasmus (@jesseerasmus)Photo by Jesse Erasmus (@jesseerasmus)Photo by Jesse Erasmus (@jesseerasmus)
🧵 New in @ScienceTM and on the cover! science.org/doi/10.1126/scit… After developing RNA vaccines for several different enveloped viruses, we realized that no one had done so for nonenveloped viruses. In this paper, we sought to do just that, with a focus on a prototype picornavirus.
2
24
4
73
19,627
Great collab to understand how antibodies elicited by our LION/repRNA vaccine against #CCHFV nucleoprotein mediate protection via an intracellular TRIM21 interaction. Turns out non-neutralizing antibodies can be neutralizing if they can get inside cells. nature.com/articles/s41467-0…
3
9
708
Feeling quite positive about this trip to Killarney, Ireland! Looking forward to some good science
2
171
Our CCHF and NiV programs continue to hit milestones. Looking forward to continued success!
This Post is from an account that no longer exists. Learn more
1
1
8
1,049
Calling all mucosal immunologists. We are hiring a postdoc to join our team. Looking for someone interested in characterizing mucosal responses to our platform and understanding how and why they are better than those elicited by LNP vaccines. linkedin.com/jobs/view/40204…
1
3
4
1,650
Preprint on our work with NIAID/RML to understand vaccine composition requirements for protection against bovine H5N1, should it become a problem. TL;DR: HA from the stockpiled vaccine may not be ideal.
Research Square: Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine #H5N1 challenge David Hawman, Heinz Feldmann et al 👉researchsquare.com/article/r…
4
288
1/12 Enterovirus D68 (EV-D68), part of the Picornaviridae family, transmits through respiratory droplets. Since 2014, it's been linked to over 756 cases of acute flaccid myelitis in the US, mostly affecting children; highlighting the urgent need for an effective vaccine. #AFM
1
2
562
12/12 Shout out to 1st author @DrNikkiWarner21, and @JFArcher who led most of the work, and co-authors on twitter (@KhandharAmit @Taishi_Kimura @VogtVirusLab) and not (Stephanie Park et al) for contributing to massive effort. Stay tuned for more updates! #scienceresearch
1
4
221
If anyone access to the full copy of this paper, head over to hdt.bio/publications/ and use the special link there! (only allowed to provide the link in one place)
74
A self-amplifying mRNA vaccine for enteroviruses shows promise in mice and large animals, researchers identify a plant-based compound that could combat hearing loss from powerful antibiotics, and more this week in #ScienceTranslationalMedicine. scim.ag/7WW
3
5
2
48
28,374
Jesse Erasmus retweeted
Our lab's new publication, led by Nuthan and Josh, investigates whether the route of administration and delivery vehicle impacts the protein expression from saRNA. sciencedirect.com/science/ar…
2
7
19
2,715
I sure do love to see the picornaviruses getting some attention. Great work here 👇
🧵 New in @ScienceTM and on the cover! science.org/doi/10.1126/scit… After developing RNA vaccines for several different enveloped viruses, we realized that no one had done so for nonenveloped viruses. In this paper, we sought to do just that, with a focus on a prototype picornavirus.
2
30
10,063
I’m pumped to see this work in print! Congrats to the @hdtbio crew on a very cool EV-D68 vaccine. This was a fantastic way to debut our #AFM mouse model. Glad you brought us on and congrats on getting the cover, to boot!
🧵 New in @ScienceTM and on the cover! science.org/doi/10.1126/scit… After developing RNA vaccines for several different enveloped viruses, we realized that no one had done so for nonenveloped viruses. In this paper, we sought to do just that, with a focus on a prototype picornavirus.
2
5
20
2,784